The ETS Gene ETV4 Is Required for Anchorage-Independent Growth and a Cell Proliferation Gene Expression Program in PC3 Prostate Cells
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Chromosomal abnormalities that give rise to elevated expression levels of the ETS genes ETV1, ETV4, ETV5, or ERG are prevalent in prostate cancer, but the function of these transcription factors in carcinogenesis is not clear. Previous work in cell lines implicates ERG, ETV1, and ETV5 as regulators of invasive growth but not transformation. Here we show that the PC3 prostate cancer cell line provides a model system to study the over-expression of ETV4. Migration assays, anchorage independent growth assays, and microarray analysis indicate that high ETV4 expression contributes to both transformation and cellular motility in PC3 cells. ETV4 directly bound the 5' and 3' MYC enhancers and modulated expression of both MYC and other cell proliferation genes, demonstrating a potential role in cell growth control. Despite this novel role for ETV4 in anchorage independent growth, ETV4 over-expression in normal prostate-derived RWPE-1 cells showed effects similar to ETV1 over-expression - increased cellular motility, and an up-regulation of genes encoding extracellular proteins as well as ones important for development, inflammation, and wound healing. Because ETV1 and ETV4 have similar roles when introduced to the same cellular background, we suggest that the requirement of high ETV4 expression for maintenance of the anchorage-independent growth in PC3 cells is due to a specific characteristic of this cell line rather than a function of ETV4 that is distinct from the other oncogenic ETS genes. Thus, the function of ETS genes in prostate cancer may differ based on other genetic alterations in a tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn, M. E., Ks, N., Ohnuki, Y., Lechner, J. F., & Jones, L. W. (1979) · PubMed · Cited by 2,156
LNCaP model of human prostatic carcinoma.
Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H. E., Chu, T. M., MIRAND, E. A., & Murphy, G. P. (1983) · PubMed · Cited by 1,789
The ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086 · cited 1×
“The ETS family transcription factors, including the 28 human paralogs, all have a conserved ETS DNA binding domain.(10,11) This results in similar DNA sequence recognition throughout the family and the potential for overlapping transcriptional targets.”
BackgroundAndrogen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Wang, Q., Li, W., Zhang, Y., Yuan, X., Xu, K., Yu, J., Chen, Z., Beroukhim, R., Wang, H., Lupien, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.056 · Cited by 902 · cited 1×
“It has been reported recently that the enhancer regions accessible for AR binding differ between androgen-independent and -dependent cells.(27) Interestingly, the types of genes associated with enhancers preferentially targeted in androgenindependent cells are similar to the genes downregulated by ETV4 knockdown in PC…”
BackgroundDistinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Tomlins, S. A., Laxman, B., Dhanasekaran, S. M., Helgeson, B. E., Cao, X., Morris, D. S., Menon, A., Jing, X., Cao, Q., Han, B., et al. (2007) · Nature · doi:10.1038/nature06024 · Cited by 844 · cited 5×
“Previous studies indicate that the exogenous expression of ERG, ETV1, and ETV5 in cell lines derived from normal prostate increases growth in invasion assays but does not promote transformation in anchorage-independent growth assays.(6,13,14) Similarly, reduction of ERG or ETV1 expression in V-CAP or LN-CAP prostate c…”
BackgroundMethodResultInfluentialTelomerase maintains telomere structure in normal human cells
Kenichi, M., Yu, E. Y., Shilagardi, K., Ben‐Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Seishi, M., DeCaprio, J. A., et al. (2006) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 738
Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
Tomlins, S. A., Laxman, B., Varambally, S., Cao, X., Yu, J., Helgeson, B. E., Cao, Q., Prensner, J. R., Rubin, M. A., Shah, R. B., et al. (2008) · Neoplasia · doi:10.1593/neo.07822 · Cited by 690
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688 · cited 1×
“The ETS family transcription factors, including the 28 human paralogs, all have a conserved ETS DNA binding domain.(10,11) This results in similar DNA sequence recognition throughout the family and the potential for overlapping transcriptional targets.”
BackgroundRecurrent gene fusions in prostate cancer
Kumar-Sinha, C., Tomlins, S. A., & Chinnaiyan, A. M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2402 · Cited by 664 · cited 2×
“Thus, it has been proposed that these 4 ETS proteins have overlapping or redundant functions that promote prostate carcinogenesis.(8,9) However, the oncogenic mechanism of these ETS proteins is still unclear.”
BackgroundMethodAberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Carver, B. S., Tran, J., Gopalan, A., Chen, Z., Shaikh, S., Carracedo, A., Alimonti, A., Nardella, C., Varmeh, S., Scardino, P. T., et al. (2009) · Nature Genetics · doi:10.1038/ng.370 · Cited by 659 · cited 1×
“The context dependence of ETV4 function is consistent with the ability of overexpressed ERG to synergistically promote transformation in concert with other oncogenic mutations such as PTEN deletion and overexpression of androgen receptor (AR).(20,21) Unique signaling characteristics resulting from the activating K-RAS…”
BackgroundTMPRSS2:ETV4 Gene Fusions Define a Third Molecular Subtype of Prostate Cancer
Tomlins, S. A., Mehra, R., Rhodes, D. R., Smith, L. R., Roulston, D., Helgeson, B. E., Cao, X., Wei, J. T., Rubin, M. A., Shah, R. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0168 · Cited by 469 · cited 1×
“Interestingly, the chromosomal rearrangements described thus far in prostate cancers result in versions of ETV4 that lack the N-terminal amino acids encoded by either exon 2 or exons 2 to 4.(5,17,18) Our data suggest that alternative mechanisms by which prostate cancer cells alter full-length ETV4 expression may play…”
BackgroundBello, D. (1997) · Carcinogenesis · doi:10.1093/carcin/18.6.1215 · Cited by 438
Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.
Vlietstra, R. J., van Alewijk, D. C., Hermans, K., van Steenbrugge, G. J., & Trapman, J. (1998) · PubMed · Cited by 381
Hollenhorst, P. C., Shah, A. A., Hopkins, C., & Graves, B. J. (2007) · Genes & Development · doi:10.1101/gad.1561707 · Cited by 290 · cited 1×
“This results in similar DNA sequence recognition throughout the family and the potential for overlapping transcriptional targets.(12) Phylogenetic analysis of the family reveals subfamilies that exhibit sequence conservation beyond the DNA binding domain.”
BackgroundSelf-citationCharacterization of TMPRSS2:ETV5 and SLC45A3:ETV5 Gene Fusions in Prostate Cancer
Helgeson, B. E., Tomlins, S. A., Shah, N., Laxman, B., Cao, Q., Prensner, J. R., Cao, X., Singla, N., Montie, J. E., Varambally, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5352 · Cited by 276 · cited 1×
“Previous studies indicate that the exogenous expression of ERG, ETV1, and ETV5 in cell lines derived from normal prostate increases growth in invasion assays but does not promote transformation in anchorage-independent growth assays.(6,13,14) Similarly, reduction of ERG or ETV1 expression in V-CAP or LN-CAP prostate c…”
BackgroundLessnick, S. L., Dacwag, C. S., & Golub, T. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00056-9 · Cited by 264
Sun, C., Dobi, A., Mohamed, A., Li, H., Thangapazham, R. L., Furusato, B., Shaheduzzaman, S., Tan, S.-H., Vaidyanathan, G., Whitman, E., et al. (2008) · Oncogene · doi:10.1038/onc.2008.183 · Cited by 253 · cited 1×
“Two recent studies have identified MYC as a target of ERG in prostate cells.(20,28) This indicates a possible overlapping role of ETV4 and ERG in the regulation of cellular proliferation consistent with an overlapping function in prostate cancer.”
BackgroundMosquera, J.-M., Mehra, R., Regan, M. M., Perner, S., Genega, E. M., Bueti, G., Shah, R. B., Gaston, S., Tomlins, S. A., Wei, J. T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2927 · Cited by 234
Hollenhorst, P. C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh906 · Cited by 214 · cited 13×
“The cell cycle and cell proliferation genes affected by ETV4 knockdown in PC3 cells are either direct or indirect targets of ETV4.”
BackgroundMethodSelf-citationZong, Y., Xin, L., Goldstein, A. S., Lawson, D. A., Teitell, M. A., & Witte, O. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905931106 · Cited by 203 · cited 2×
“The context dependence of ETV4 function is consistent with the ability of overexpressed ERG to synergistically promote transformation in concert with other oncogenic mutations such as PTEN deletion and overexpression of androgen receptor (AR).(20,21) Unique signaling characteristics resulting from the activating K-RAS…”
BackgroundHan, B., Mehra, R., Dhanasekaran, S. M., Yu, J., Menon, A., Lonigro, R. J., Wang, X., Gong, Y., Wang, L., Shankar, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2014 · Cited by 154
Two Unique Novel Prostate-Specific and Androgen-Regulated Fusion Partners of ETV4 in Prostate Cancer
Hermans, K. G., Bressers, A. A., van der Korput, H. A., Dits, N. F. J., Jenster, G. W., & Trapman, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0198 · Cited by 124
ETV1 Is a Novel Androgen Receptor-Regulated Gene that Mediates Prostate Cancer Cell Invasion
Cai, C., Hsieh, C.-L., Omwancha, J., Zheng, Z., Chen, S.-Y., Baert, J.-L., & Shemshedini, L. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0480 · Cited by 120
Yochum, G. S., Cleland, R., & Goodman, R. H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00744-08 · Cited by 115
Testing mutual exclusivity of ETS rearranged prostate cancer
Svensson, M. A., Lafargue, C. J., MacDonald, T. Y., Pflueger, D., Kitabayashi, N., Santa-Cruz, A. M., Garsha, K. E., Sathyanarayana, U. G., Riley, J., Yun, C. S., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.179 · Cited by 81 · cited 3×
“Chromosomal rearrangements in prostate cancers rarely result in overexpression of more than one of the ETS genes: ETV1, ETV4, ETV5, or ERG.(7) This exclusive pattern of expression should also occur in cell lines used as models of ETS overexpression in prostate cancer.”
BackgroundYamamoto, H. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh011 · Cited by 75
ETS2 function is required to maintain the transformed state of human prostate cancer cells
Sementchenko, V. I., Schweinfest, C. W., Papas, T. S., & Watson, D. K. (1998) · Oncogene · doi:10.1038/sj.onc.1202220 · Cited by 75 · cited 1×
“A previous report found that a nonspecific inhibitor of ETS function and an antisense knockdown of ETS2 also decrease soft agar growth of PC3 cells.(19) Thus, ETS proteins appear to play a critical, and possibly redundant, role in transformation in this particular cellular background.”
BackgroundTurner, D. P., & Watson, D. K. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.1.33 · Cited by 72 · cited 1×
“Thus, it has been proposed that these 4 ETS proteins have overlapping or redundant functions that promote prostate carcinogenesis.(8,9) However, the oncogenic mechanism of these ETS proteins is still unclear.”
BackgroundTelomerase Maintains Telomere Structure in Normal Human Cells
Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00550-6 · Cited by 70
Nosho, K., Yamamoto, H., Adachi, Y., Endo, T., Hinoda, Y., & Imai, K. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602442 · Cited by 61
Firlej, V., Ladam, F., Brysbaert, G., Dumont, P., Fuks, F., de Launoit, Y., Benecke, A., & Chotteau‐Lelièvre, A. (2008) · Journal of Cell Science · doi:10.1242/jcs.027201 · Cited by 51 · cited 1×
“In fact, the necessity of ETV4 for both cellular migration and anchorage-independent growth in PC3 cells parallels findings in mouse mammary tumor cells.(35) Thus, studies into the role of ETV4 in PC3 cells may shed light on widespread oncogenic mechanisms.”
BackgroundHida, K., Shindoh, M., Yoshida, K., Kudoh, A., Furaoka, K., Kohgo, T., Fujinaga, K., & Totsuka, Y. (1997) · Oral Oncology · doi:10.1016/s0964-1955(97)00047-x · Cited by 47
Selective expression of erg isoforms in human endothelial cells
Hewett, P. W., Nishi, K., Daft, E. L., & Murray, J. C. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00022-x · Cited by 47 · cited 1×
“ERG is an ETS transcription factor with adult expression normally confined to endothelial cells.(3,4) Similar chromosomal abnormalities that result in aberrant expression of the ETS genes ETV1 (ER81), ETV4 (PEA3, E1AF), and ETV5 (ERM) occur in prostate cancer but are usually mutually exclusive with TMPRSS2-ERG.”
BackgroundPergolizzi, R. G., Kreis, W., Rottach, C., Susin, M., & Broome, J. D. (1993) · Cancer Investigation · doi:10.3109/07357909309020257 · Cited by 39
Izumiyama, Y., Ohiro, Y., Higashino, F., Yoshida, K., Taguchi, K., Todo, S., Kohgo, T., Totsuka, Y., & Shindoh, M. (2005) · Oncology Reports · doi:10.3892/or.13.4.715 · Cited by 17
Association of E1AF mRNA Expression with Tumor Progression and Matrilysin in Human Rectal Cancer
Liu, H.-Y., Zhou, B., Ling, W., Li, Y., Zhou, Z., Sun, X., Xu, B., Zeng, Y., Song, J., Luo, H.-Z., et al. (2007) · Oncology · doi:10.1159/000136158 · Cited by 15
Hata, H., Kitamura, T., Higashino, F., Hida, K., Yoshida, K., Ohiro, Y., Totsuka, Y., Kitagawa, Y., & Shindoh, M. (2008) · Oncology Reports · doi:10.3892/or.19.5.1093 · Cited by 7
Cited by
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
Self-citationETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors
Oh, S., Shin, S., & Janknecht, R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.002 · Cited by 249
Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells
Hollenhorst, P. C., Ferris, M. W., Hull, M. A., Chae, H., Kim, S., & Graves, B. J. (2011) · Genes & Development · doi:10.1101/gad.17546311 · Cited by 154
Self-citationmiR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT
Kao, C.-J., Martiniez, A., Shi, X.-B., Yang, J. C., Evans, C. P., Dobi, A., White, R. D., & Kung, H.-J. (2013) · Oncogene · doi:10.1038/onc.2013.200 · Cited by 155
“A similar trend is also observed for PC3 cells expressing ETV4, a close homologue of ERG (50) (data not shown).”
BackgroundAytés, À., Mitrofanova, A., Kinkade, C. W., Lefèbvre, C., Lei, M., Phelan, V., Lekaye, C., Koutcher, J. A., Cardiff, R. D., Califano, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303558110 · Cited by 153
“Notably, these ETS transcription factors have been previously implicated in mediating Ras signaling in prostate (49, 50) and other cancers (51, 52), as well as in regulation of EMT markers, including Snail (53, 54).”
Background
Metadata
- Authors
- Hollenhorst, P. C., Paul, L., Ferris, M. W., & Graves, B. J.
- Affiliations
- Indiana University Bloomington (US)
- University of Utah (US)
- Indiana University School of Medicine (US)
- Corresponding author
- Hollenhorst, P. C.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2010-10-01
- Volume
- 1
- Issue
- 10
- Pages
- 1044-1052
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- PMC
- PMC3046414
- OpenAlex
- W2007760033
- Cited by
- 62
- References
- 37
- Citations by year
- 2026: 2 · 2025: 2 · 2023: 4 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 3 · 2015: 5 · 2014: 5 · 2013: 5 · 2012: 8
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Genes & Cancer (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Utah
- National Cancer Institute (P30CA042014)
- National Institute of General Medical Sciences (R01GM038663)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- ETV4, ETS transcription factors, prostate cancer, anchorage-independent growth, cell proliferation, cell motility, cell transformation, ETV1, ERG, ETV5, PC-3 cells, RWPE-1 cells, extracellular matrix genes, wound healing genes, chromosomal abnormalities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.